期刊文献+

P16基因启动子在脑胶质瘤患者中的异常甲基化及意义 被引量:1

THE SIGNIFICANCE OF P16 GENE PROMOTER HYPERMETHYLATION IN PATIENTS WITH GLIOMAS
下载PDF
导出
摘要 目的探讨脑胶质瘤患者肿瘤与血浆标本P16基因启动子区CpG岛的甲基化状态及其与临床的关系,分析脑胶质瘤的可能发生机制及早期诊断方法。方法用甲基化特异性PCR对40例脑胶质瘤患者肿瘤及血浆标本P16基因启动子区进行甲基化检测。结果 40例脑胶质瘤标本的P16基因启动子区异常甲基化率为35%(14/40),相应血浆标本的P16的异常甲基化检出率为25%(10/40),两者相比差异无显著性(p>0.05)。20例对照组脑组织标本的P16基因甲基化率为5%(1/20),与胶质瘤标本比较差异具有统计学意义(p<0.05)。P16基因启动子区的异常甲基化与患者年龄、性别、肿瘤病理类型、恶性程度的差异无统计学意义(p>0.05)。结论 P16基因启动子区CpG岛的异常甲基化在脑胶质瘤的发生中起着重要作用,检测血浆标本的P16的异常甲基化对于脑胶质瘤早期诊断具有重要意义。 Objective To investigate the methylation status of the CpG islands in the promoter regions of P16 gene in cancer tissue and peripheral plasma of patients with gliomas and to analyze its clinical significance,discussing the possible mechanism and early diagnosis technique of gliomas. Methods We analyzed the hypermethylation status of P16 gene in 40 glioma tissues and corresponding blood plasma of glioma patients by methylation specific-PCR. Results The frequency of methylation of Promoter of RASSF1A gene was 35%(14/40)in glioma tissue,25%(10/40)in peripheral blood plasma,there was no significant difference(p0.05).Frequency of methylation was 5%(1/20) in normal brain tissue,which has significant difference from the glioma tissue.no significant association of abnormal methylation was also identified with the patient's gender,age,pathological type,pathological stage(p0.05). Conclusion Hypermethylation of CPG islands in the promoter of P16 gene in gliomas may contribute to the development of gliomas.Detection of hypermethylation of P16 in blood plasma of glioma patients is valuable in early diagnosis of gliomas.
出处 《现代医院》 2011年第9期9-12,共4页 Modern Hospitals
基金 广东省医学科研基金(编号:A2010466) 广东省中医药局科研立项(编号:A2010020) 广州市医药卫生科技一般引导项目立项项目(编号:2009-YB-042) 广州市中医药 中西医结合科研课题(编号:2009A25)
关键词 胶质瘤 P16基因 甲基化 甲基化特异性PCR Gliomas P16 gene Methylation Methylation special PCR(MSP)
  • 相关文献

参考文献9

  • 1STANGANELLI C,ARBELBIDE J,FANTL D.B,ET AL.DNA methylation analysis of tumor suppressor genes in monoclonal gammopathy of undetermined significance[J].Annals of Hematology,2010,89(2):191-199.
  • 2BELLO MJ,REY J A.The p53/Mdm2/p14ARF cell cycle control pathway genes may be inactivated by genetic and epigenetic mechanisms in gliomas[J].Cancer Genet Cytogenet,2006,164(2):172-173.
  • 3YUREGIR O O,YURTCU E,KIZILKILIC E,et al.Detecting methylation patterns of p16,MGMT,DAPK and E-cadherin genes in multiple myeloma patients[J].International Journal of Laboratory Hematology,2010,32(2):142-149.
  • 4HERMAN JG,GRAFT JR,MYOHANEN S,et al.Methylation-specific PCR:A novel PCR assay for methylation status of CpG islands[J].Proe Natl Sci USA,1996,93:9821-9826.
  • 5SALAM I,HUSSAIN S,MIR M M,et al.Aberrant promoter methylation and reduced expression of p16 gene in esophageal squamous cell carcinoma from Kashmir valley:a high-risk area[J].Molecular and Cellular Biochemistry,2009,332 (1):51-58.
  • 6DE SOUZA NASCIMENTO P,MACIEL C M,KAWAMURA M T,et al.Molecular analysis of CDKN2(pl6)in gliomas associated with clinical data[J].Oncol Rep,2001,8(5):1039-1043.
  • 7BALANA C,RAMIREZ J L,TARON M,et al.06-methyl-guanine-DNA methyltransferase methylation in serum and tumor DNA predicts response to 1,3-bis(2-chloroethy1)-1 nitrosourea but not to temozolamide plus cisplatin in glioblastoma multiforme[J].Clin Cancer Res,2003,9(4):l461-1468.
  • 8RAMIREZ JL,TARON M,BALANA C,et al.Serum DNA as a tool for cancer patient management[J].Rocz Akad Med Bialymst,2003,48:34-41.
  • 9WEAVER K D,GROSSMAN S A,HERMAN J G.Methylated tumor-specific DNA as a plasma biomarker in patients with glioma[J].Cancer Invest,2006,24(1):35-40.

同被引文献6

  • 1张振兴,管立学,王成东,王道奎,李海波,王敬先,王瑞丽.瘤组织和血浆中P16基因CpG岛甲基化与脑肿瘤生物学行为的关系[J].潍坊医学院学报,2006,28(3):184-187. 被引量:2
  • 2王喆,曹培成,张振兴,王成东,闫红梅,王道奎,王永和,管立学.p16基因CpG岛甲基化与胶质瘤生物学特性的关系[J].中华神经外科疾病研究杂志,2007,6(4):311-314. 被引量:5
  • 3Holdt L M, Teupser D. Recent studies of the human chromosome 9p21 locus, which is associated with atherosclerosis in human pop- ulations [ J]. Arterioscler Thromb Vasc Biol, 2012,32(2) :196 - 206.
  • 4Leon S A, Shapiro B, Sklaroff D M, et al. Free DNA in the serum of cancer patients and the effect of therapy [ J ]. Cancer Res, 1977,37 ( 3 ) :646 - 50.
  • 5Stroun M, Anker P, Maurice P, et al. Neoplastic characteristics of the DNA found'in the plasma of cancer patients[ J]. Oncology, 1989, 46(5) : 318 -22.
  • 6Wakabayashi T, Natsume A, Hatano H, et al. p16 promoter methylation in the serum as a basis for the molecular diagnosis of gliomas [ J ]. Neumsurgery,2009,64 ( 3 ) :455 - 61.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部